The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Nicotine receptor partial agonists for smoking cessation
Open accessAbstract
Nicotine receptor partial agonists for smoking cessation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of effective drugs to treat nicotine-dependence (e.g., nicotine patches, nicotine gum, and varenicline)356, 357) combined with counseling for psychological dependence increase the success rate of smoking cessation.”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [356]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,564
Self-citationAntidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243
Self-citationAnthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Flagged first, then by citations
Research works printed but not linked: 38
- Aubin, 2008, Authors' reply [to JE Rose], Thorax, 63, 752
- Aubin, 2008, Authors' reply [to T Hillman], Thorax, 63, 752
- Brinn, 2013, Cost effectiveness of an inpatient smoking cessation intervention for patients with tobacco related illnesses (Stop Trial): a multi-centre RCT [Abstract], Respirology (Carlton, Vic.), 18, 16 [O027]
- Carson, 2015, Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 24-month randomized controlled trial for inpatients, Respirology, 20, 115
- Carson, 2010, Varenicline tartrate and counselling versus counselling alone in a randomised controlled trial for inpatient smoking cessation: 3 month interim results [Abstract], Respirology, 15, A30
- Hnin, 2014, Triggers resulting in relapse: cohort analysis from the smoking termination opportunity for inpatients (STOP) trial [Abstract], Respirology (Carlton, Vic.), 19, 40 [TO 076]
- Anthenelli R Benowitz N West R St Aubin L McRae T Lawrence D Reports of suicidal ideation and behavior in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
- Benowitz N Evins AE West R St Aubin L McRae T Lawrence D EAGLES trial: study design and neuropsychiatric safety results Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
- Prochaska J Neuropsychiatric risk concerns in the context of smoking, quitting, and cessation pharmacotherapy use Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
- Prochaska J Benowitz N West R Anthenelli R Evaluating adverse events in a global smoking cessation study (EAGLES): a randomized controlled tiral comparing the safety and efficacy of the first-line smoking cessation aids in smokers with and without pychiatric disorders Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
- West R Benowitz N Evins AE St Aubin L McRae T Lawrence D Relative efficacy of varenicline, bupropion SR, and nicotine transdermal patch in aiding smoking cessation in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
- Bastian H Comment on Ebbert 2015 'Reduce to Quit' trial www.ncbi.nlm.nih.gov/pubmed/?term=25688780
- Evins, 2013, Extended duration pharmacotherapy with varenicline prevents relapse to smoking in adult smokers with schizophrenia, Neuropsychopharmacology, 38, S63
- Meszaros, 2012, Varenicline treatment of alcohol and nicotine dependence in schizophrenia: Problems encountered in a pilot trial, American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 21, 393
- Nakamura, 2007, Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers, Clinical Therapeutics, 29, 1040, 10.1016/j.clinthera.2007.06.012 · DOI
- Rigotti, 2010, A randomized trial of varenicline for smoking cessation in patients with cardiovascular disease: analysis of efficacy by baseline characteristics, Circulation, Conference, 2
- Benndorf, 1970, Smoking cessation treatment with cytisin (Tabex®): half-yearly outcomes for former smokers abstinent at four weeks from beginning of treatment, Das Deutsche Gesundheitwesen, 24, 774
- Benndorf, 1969, Further reports on a double blind trial of the Bulgarian cytisine compound Tabex® on 1214 smokers wishing to quit and practical experience in conducting clinics for such smokers, Das Deutsche Gesundheitswesen, 24, 1135
- Benndorf, 1968, Results of smoking cessation treatment with cytisin (Tabex®), Das Deutsche Gesundheitwesen, 23, 2092
- Scharfenberg, 1971, Cytisine (Tabex®) as a treatment for smoking cessation, Das Deutsche Gesundheitwesen, 26, 463
- O'Brien, 2007, Varenicline as maintenance therapy, Current Psychiatry Reports, 9, 348
- Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
- Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
- Westergaard, 2014, The effect of varenicline on smoking cessation in a group of young asthma patients, American Journal of Respiratory and Critical Care Medicine, 189, A1091
- Reeves K Watsky E Williams K Azoulay S Billing B Gong J The safety of varenicline taken for 52 weeks for smoking cessation [RPOS3-54] Society for Research on Nicotine and Tobacco 12th Annual Conference Orlando Fla, USA 2006
- Falk, 2014, A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence, Alcoholism, Clinical and Experimental Research, 38, 139A
- Granatowicz, 1976, Smoking cessation through the use of cytisine and other therapy, World Smoking Health, 1, 8
- Hartwell, 2014, Pharmacogenetics of naltrexone and varenicline in heavy drinking smokers, Alcoholism, Clinical and Experimental Research, 38, 223A
- Bacvarov, 1967, Smoking cessation through medication: remarks on G. Scharfenberg, E Winkelvoss and S. Benndorf, Munch Med Wschr. 109 (1967) 1687-1689, Munchener Medizinische Wochenschrift, 109, 2663
- Kempe, 1967, Observation about the Bulgarian medicine for smoking withdrawal Tabex, produced by Pharmachim-Sofia, Savr Med, 18, 355
- Paun, 1968, [Smoking cessation with cytisine 'Tabex' tablets] [German], Sonderduck aus das deutsche Gesundheitwesen, 23, 2088
- Paun, 1970, Tabex: registering and treatment of smokers with chronic bronchitis in the consultation against tobacco smoking - Berlin, Medico-Biologic Information, 3, 15
- Shim, 2011, Varenicline treatment for smoking cessation in people with schizophrenia: a randomized double-blind placebo-controlled trial, Schizophrenia Bulletin, 37, 320
- Stoyanov, 1972, [On the therapeutic effectiveness and tolerability of Tabex] [Bulgarian], Savremenna Medicina, 23, 30
- Wiratmoko, 2013, Efficacy of varenicline, an nicotinic acetylcholine receptor partial agonist, vs placebo for smoking cessation. A randomized controlled trial, Respirology (Carlton, Vic.), 18, 66 [OS205]
- Reid, 2010, Varenicline versus transdermal nicotine patch for smoking cessation in patients with coronary heart disease: A pilot randomized trial, Canadian Journal of Cardiology, 26, 53D
- Smith, 2013, Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia, Neuropsychopharmacology, 38, S364
- Tutka, 2006, Cytisine - renaissance of well known alkaloid. Pharmacological aspects of efficacy in the treatment of tobacco dependence [Polish], Farmakoterapia w Psychiatrii i Neurologii, 1, 33
Cited by
Sorted by citations
Items 201–300 of 432
McCarthy, D. E., & Versella, M. V. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty157 · Cited by 10
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
Moerke, M. J., McMahon, L. R., & Wilkerson, J. L. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018028 · Cited by 11
Neuregulin signaling pathway in smoking behavior
Gupta, R., Qaiser, B., He, L., Hiekkalinna, T., Zheutlin, A. B., Therman, S., Ollikainen, M., Ripatti, S., Perola, M., Salomaa, V. V., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.183 · Cited by 11
Mediators of the effect of nicotine pre‐treatment on quitting smoking
Hájek, P., Lewis, S., Munafo, M. R., Lindson, N., Coleman, T. J., Aveyard, P. N., & on behalf of the The Preloading Investigators (2018) · Addiction · doi:10.1111/add.14401 · Cited by 11
Acetylcholine Receptor Structure
Luo, J., & Lindstrom, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-73585-6_2 · Cited by 11
Lin, H., Liu, Z., Hájek, P., Zhang, W., Wu, Y., Zhu, B., Liu, H., Xiang, Q., Zhang, Y., Li, S., et al. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.7846 · Cited by 9
RetractedSmoking Cessation Strategies After Acute Coronary Syndrome
Nazir, A., Ujjar, S. S., Seddiki, M., Jheinga, M., & Fan, L. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041388 · Cited by 9
Богачевская, С. А., & Николаевич, Б. А. (2017) · Social Aspects of Population Health · doi:10.21045/2071-5021-2017-53-1-1 · Cited by 10
Anraad, C., Cheung, K. L., Hiligsmann, M., Coyle, K., Coyle, D., Owen, L., West, R., de Vries, H., Evers, S., & Pokhrel, S. (2018) · Addiction · doi:10.1111/add.14093 · Cited by 8
Deligia, F., Murineddu, G., Gotti, C., Ragusa, G., Fasoli, F., Sciaccaluga, M., Plutino, S., Fucile, S., Loriga, G., Asproni, B., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.04.026 · Cited by 9
Effects of lorcaserin (Belviq®) on nicotine- and food-maintained responding in non-human primates
Jacobs, D. S., Barkin, C. E., Kohut, M. R., Bergman, J., & Kohut, S. J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.09.008 · Cited by 9
Lee, L. J., Li, Q., Bruno, M., Emir, B., Murphy, B., Shah, S., Reynolds, M. W., Marchant, N., & Park, P. W. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0858-y · Cited by 10
Ruiz, C. A. J., Solano-Reina, S., de Higes-Martínez, E., Cabrera-César, E., Sandoval-Contreras, R., de Granda‐Orive, J. I., Riesco-Miranda, J. A., Miñana, J. S.-C., Lorza-Blasco, J. J., Martínez-Muñiz, M. Á., et al. (2022) · Open Respiratory Archives · doi:10.1016/j.opresp.2022.100175 · Cited by 10
Challenges and perspectives of tobacco cessation in special groups of patients and populations
Tsikrika, S., Dai, S., Dilektaşlı, A. G., Katsaounou, P. A., & Dağlı, E. (2023) · Breathe · doi:10.1183/20734735.0224-2022 · Cited by 9
Smoking cessation pharmacotherapy; varenicline or bupropion?
Rahimi, F., Massoudifar, A., & Rahimi, R. (2024) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-024-00539-6 · Cited by 8
Brazilian Society of Angiology and Vascular Surgery guidelines on peripheral artery disease
Erzinger, F. L., Polimanti, A. C., Pinto, D. M., Murta, G. B., Cury, M. V. M., da Silva, R. B., Biagioni, R. B., Belczak, S. Q., Joviliano, E. É., de Araújo, W. J. B., et al. (2024) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.202300592 · Cited by 10
Talukder, S. R., Lappin, J., Boland, V. C., McRobbie, H. J., & Courtney, R. J. (2021) · Tobacco Control · doi:10.1136/tobaccocontrol-2021-056843 · Cited by 8
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences?
Baldacci, S., Maio, S., Meschi, C., Chimera, D., Tagliaferro, S., Angino, A. A., Silvi, P., Pistelli, F., & Carrozzi, L. (2022) · Precision Cancer Medicine · doi:10.21037/pcm-21-54 · Cited by 8
Spirometry and Smoking Cessation in Primary Care: The ESPIROTAB STUDY, A Randomized Clinical Trial
Rodríguez-Álvarez, M. D. M., Roca-Antonio, J., Martínez-González, S., Vilà-Palau, V., Chacón, C., Ortega-Roca, A., Borrell-Thió, E., Erazo, S., Almirall, J., & Torán‐Monserrat, P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114557 · Cited by 8
Gottsäter, A. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.07.004 · Cited by 8
Wang, J., Wang, M., Liu, S., Du, X.-F., Han, M., Liu, J., Qin, W., Chen, B., van Haselen, R. A., & Liu, J. (2018) · Tobacco Induced Diseases · doi:10.18332/tid/86330 · Cited by 8
Vhora, I., Bardoliwala, D., Ranamalla, S. R., & Javia, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-3642-3_7 · Cited by 8
Madae’en, S., Obeidat, N. A., & Adeinat, M. (2020) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-020-00270-y · Cited by 8
Hsueh, K.-C., Tang, P., & McRobbie, H. J. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab018 · Cited by 9
Cue restricted smoking increases quit rates with varenicline
Issa, J. S., Abe, T. M. O., Gaya, P. V., Bellini, B. B., de Moraes, I. R. A., Santos, J. M. B., Tomaz, P. R. X., Santos, P. D. L., & Tonstad, S. (2021) · Tobacco Prevention & Cessation · doi:10.18332/tpc/133570 · Cited by 8
Galantamine as a Treatment Option for Nicotine Addiction
Jamali, Q., & Bittoun, R. (2021) · The Journal of Smoking Cessation · doi:10.1155/2021/9975811 · Cited by 8
Grande, M. R. L., Borland, R., Yong, H., McNeill, A. D., Fong, G. T., & Cummings, K. M. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab230 · Cited by 8
Patel, M. S., Patel, S. B., & Steinberg, M. B. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202112210 · Cited by 9
Borrelli, B., Endrighi, R., Jurasic, M. M., Hernandez, H., Jones, E. A., Ospina, J., Cabral, H., Quintiliani, L. M., & Werntz, S. (2022) · BMC Public Health · doi:10.1186/s12889-022-13427-y · Cited by 9
Pintarelli, G., Galvan, A., Pozzi, P., Noci, S., Pasetti, G., Sala, F., Pastorino, U., Boffi, R., & Colombo, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-16946-6 · Cited by 8
Huber, M. B., Präger, M., Coyle, K., Coyle, D., Lester‐George, A., Trapero‐Bertran, M., Németh, B., Cheung, K. L., Stark, R. G., Vogl, M., et al. (2017) · Addiction · doi:10.1111/add.14062 · Cited by 7
Ten-year experience of smoking cessation in a single center in Japan
Tomioka, H., Wada, T., Yamazoe, M., Yoshizumi, Y., Nishio, C., & Ishimoto, G. (2019) · Respiratory Investigation · doi:10.1016/j.resinv.2019.01.007 · Cited by 8
Theodoulou, A., Fanshawe, T. R., Leavens, E. L. S., Theodoulou, E., Wu, A. D., Heath, L., Stewart, C., Nollen, N. L., Ahluwalia, J. S., Butler, A. R., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015120.pub2 · Cited by 13
Self-citationRecommendations on interventions for tobacco smoking cessation in adults in Canada
Thombs, B. D., Traversy, G., Reynolds, D. L., Lang, E., Groulx, S., & Wilson, B. J. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241584 · Cited by 11
Tabaquismo, el gran olvidado en el cálculo y abordaje del riesgo cardiovascular
Minué-Lorenzo, C., & Olano-Espinosa, E. (2018) · Medicina Clínica · doi:10.1016/j.medcli.2018.07.004 · Cited by 7
Evaluation of varenicline usage on ventricular repolarization after smoking cessation
Yıldırım, D. İ., Hayıroğlu, M. İ., Ünal, N., & Eryılmaz, M. A. (2018) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12609 · Cited by 7
Kuijper, F. M., Mahajan, U. V., Ku, S., Barbosa, D. A. N., Alessi, S. M., Stein, S. C., Kampman, K. M., Bentzley, B. S., & Halpern, C. H. (2021) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13410 · Cited by 6
Recent Updates of Pharmacotherapy for Smoking Cessation
Hwang, J. S., & Lee, C. M. (2021) · Korean Journal of Family Practice · doi:10.21215/kjfp.2021.11.6.403 · Cited by 7
Documento de consenso sobre tabaquismo y riesgo vascular
Alemán, J. A., Sabarís, R. C., Pardo, D. E., Donaire, J. A. G., Romanos, F. G., Iturralde-Iriso, J., Penagos, L. M., Iglesias, L. J. N., de Salinas, A. P. M., Robles, N. R., et al. (2024) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(24)00075-8 · Cited by 9
A Review of the Organic Synthesis and Medicinal Applications of the Natural Product Cytisine
Bartusik‐Aebisher, D., Aebisher, D., & Tutka, P. (2016) · Modern Organic Chemistry Research · doi:10.22606/mocr.2016.11002 · Cited by 7
Algorithms for smoking-cessation support in health care. 'Let me ask You: do You smoke?'
Gambaryan, M. G., & Drapkina, O. M. (2019) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20192203157 · Cited by 8
Smoking cessation: strategies and effects in primary and secondary cardiovascular prevention
Stanel, S. C., & Rivera‐Ortega, P. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.20.04241-x · Cited by 7
Influence of Prolonged Serotonin and Ergovaline Pre-Exposure on Vasoconstriction Ex Vivo
Valente, É. E. L., Harmon, D. L., & Klotz, J. L. (2021) · Toxins · doi:10.3390/toxins14010009 · Cited by 7
Erzinger, F. L., Polimanti, A. C., Pinto, D. M., Murta, G. B., Cury, M. V. M., da Silva, R. B., Biagioni, R. B., Belczak, S. Q., Joviliano, E. É., de Araújo, W. J. B., et al. (2024) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.202300591 · Cited by 7
Molero, Y., Zetterqvist, J., Lichtenstein, P., Almqvist, C., & Ludvigsson, J. F. (2018) · Clinical Epidemiology · doi:10.2147/clep.s171401 · Cited by 7
Klemperer, E. M., Hughes, J. R., & Naud, S. J. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty225 · Cited by 6
Gobarani, R. K., Zwar, N. A., Russell, G. M., Abramson, M. J., Bonevski, B., Holland, A. E., Paul, E. M., Cox, N. S., Wilson, S., & George, J. (2021) · British Journal of General Practice · doi:10.3399/bjgp.2020.0906 · Cited by 7
Ramotowski, B., & Budaj, A. (2021) · Kardiologia Polska · doi:10.33963/kp.a2021.0025 · Cited by 7
The Nicotinic Agonist Cytisine: The Role of the NH···N Interaction
Aguado, R., Mata, S., Sanz‐Novo, M., Alonso, E. R., León, Í., & Alonso, J. L. (2022) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.2c02021 · Cited by 6
Shang, J., Nie, X., Qi, Y., Zhou, J., & Qi, Y. (2023) · World Journal of Surgical Oncology · doi:10.1186/s12957-023-03099-2 · Cited by 6
Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions
Hassell, C., Wilkins, K. M., & Trevisan, L. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0107-z · Cited by 6
Sécula, F., Erismann, S., Carolina, C., Chater, A., Shabab, L., Glen, F. C., Curteanu, A., Serbulenco, A., Silitrari, N., Demişcan, D., et al. (2020) · BMC Proceedings · doi:10.1186/s12919-020-0183-8 · Cited by 6
Carney, G., Maclure, M., Taylor, S. C. M., Bassett, K. L., Wright, J. M., & Dormuth, C. R. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa100 · Cited by 6
Gobarani, R. K., Abramson, M. J., Bonevski, B., Weeks, G. R., Dooley, M. J., Smith, B. J., Veale, A., Webb, A. R., Kirsa, S. W., Thomas, D., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038184 · Cited by 7
A Genome-Wide Association Study of Nausea Incidence in Varenicline-Treated Cigarette Smokers
Chenoweth, M. J., Lerman, C. E., Knight, J., & Tyndale, R. F. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab044 · Cited by 7
Treatment of tobacco dependence
Kathuria, H., Leone, F. T., & Neptune, E. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000491 · Cited by 6
Nuevos fármacos financiados para la deshabituación del tabaco
García, R. C., & Guillem, F. C. (2023) · Atención Primaria · doi:10.1016/j.aprim.2023.102647 · Cited by 6
Chugh, A., Jain, N., & Arora, M. (2022) · Integrated science · doi:10.1007/978-3-030-85357-0_9 · Cited by 7
Varenicline and Nicotine Replacement Therapy for Smokers Admitted to Hospitals
Weeks, G. R., Gobarani, R. K., Abramson, M. J., Bonevski, B., Webb, A. R., Thomas, D., Paul, E. M., Sarwar, M. R., Smith, B. J., Perinpanathan, S., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.18120 · Cited by 6
Jimenez-Ruiz, C. A., Miranda, J. A. R., Picó, A. M., Gutiérrez, R. D. S., Miñana, J. S.-C., Muñoz, J. L., & Sellarés, J. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2022.11.015 · Cited by 5
Chen, K.-C., Hsu, C., Wu, C., Lin, K.-L., Chen, S., Lee, Y.-C., Hsu, C., Hsu, C., Huang, C.-Y., Huang, S.-H., et al. (2023) · PubMed Central · doi:10.6515/acs.202311_39(6).20230921a · Cited by 5
Torazzi, A., Tedesco, E., Ceccato, S., Santin, L., Campagnari, S., Losso, L., Toldo, S., Casari, R., Arzenton, E., Marini, P., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1350176 · Cited by 5
Ribeiro‐Carvalho, A., Leal-Rocha, P. H., Isnardo-Fernandes, J., Araújo, U. C., Abreu‐Villaça, Y., Filgueiras, C. C., & Manhães, A. C. (2021) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 5
Hata, A., Komiyama, M., Yasoda, A., Wada, H., Yamakage, H., Satoh‐Asahara, N., Morimoto, T., Takahashi, Y., & Hasegawa, K. (2022) · JMIR Research Protocols · doi:10.2196/38626 · Cited by 5
Jimenez-Ruiz, C. A., Pascual-Lledó, J. F., Cicero-Guerrero, A. M., Cristóbal-Fernández, M. I., Mayayo-Ulibarri, M., & Villar-Laguna, C. (2017) · Pulmonology · doi:10.1016/j.rppnen.2017.10.008 · Cited by 5
Jiménez-Ruiz, C. A., García-Rueda, M., Muñiz, M. A. M., Sellarés, J., Jiménez-Fuentes, M. A., Asegurado, L. L., Rodríguez, E., Rodríguez-García, C., Armengol, O., Abad, E., et al. (2017) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2017.874 · Cited by 5
Tobacco Smoking Is a Medical Problem. We Ought to Treat It Like One
Kalhan, R., Wilkins, J. T., & Hitsman, B. L. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2354ed · Cited by 5
Lindson, N., Gao, M., Hartmann‐Boyce, J., Smith, M. C., Aveyard, P. N., Young, D., Coupland, C. A. C., Tan, P. S., Clift, A. K., Harrison, D. A., et al. (2020) · medRxiv · doi:10.1101/2020.06.05.20116624 · Cited by 5
Aoike, M., Mori, Y., Aoyama, Y., Tanaka, M., Kozai, H., Shigeno, Y., Kawamura, H., Tsurudome, M., & Ito, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20065135 · Cited by 4
Effect of Funding Medications for Nicotine Dependence on Tobacco Control: A Narrative Review
Rábade, C., Morais, A., Ravara, S., de Granda‐Orive, J. I., Boléo-Tomé, J. P., Riesco-Miranda, J. A., Pinedo, Á. R., Martínez, E. D. H., Muñiz, M. Á. M., Pérez, R. P., et al. (2025) · Open Respiratory Archives · doi:10.1016/j.opresp.2025.100410 · Cited by 4
Luepker, R. V. (2016) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2016.0025 · Cited by 4
Thomas, K. H., Caldwell, D. M., Dalili, M. N., Gunnell, D., Munafo, M. R., Stevenson, M., & Welton, N. J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015414 · Cited by 4
Self-citationChenoweth, M. J., Peng, A. R., Zhu, A. Z. X., Cox, L. S., Nollen, N. L., Ahluwalia, J. S., Benowitz, N. L., Knight, J., Swardfager, W., & Tyndale, R. F. (2021) · Addiction · doi:10.1111/add.15742 · Cited by 5
Interventions for smokeless tobacco use cessation
Livingstone‐Banks, J., Siddiqui, F., Croucher, R., Mehrotra, R., Vidyasagaran, A. L., & Siddiqi, K. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015314 · Cited by 4
Assessing combined effects of varenicline and N‐acetylcysteine on reducing nicotine seeking in rats
Nall, R. W., Beloate, L. N., Meyerink, M. E., Penaloza, T., Doolittle, J. D., Froeliger, B., Kalivas, P. W., & García‐Keller, C. (2022) · Addiction Biology · doi:10.1111/adb.13151 · Cited by 4
Insula deep rTMS and varenicline for smoking cessation: A randomized control trial study protocol
Ibrahim, C., Malik, S., Barr, M. S., Blumberger, D. M., Daskalakis, Z. J., & Foll, B. L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.969500 · Cited by 4
Pharmacological smoking cessation of adults aged 30–50 years with COPD
Andelius, D. K., Hilberg, O., Ibsen, R., & Løkke, A. (2022) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-022-00301-y · Cited by 4
Pulmonary prehabilitation and smoking cessation
Ibekwe, S. O., Mondal, S., & Faloye, A. O. (2022) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001219 · Cited by 5
Haeny, A. M., Gueorguieva, R. V., Montgomery, L., Bold, K. W., Fucito, L. M., Wu, R., Muvvala, S. B., Zweben, A., & O’Malley, S. S. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106970 · Cited by 4
Risk factors and primary prevention of lung cancer. Cessation of cigarette addiction
Krawczyk, P. A., Ramlau, R., Błach, J., Kieszko, R., Roszkowski-Ślisz, K., Kucharczyk, T., Kieszko, S., & Milanowski, J. (2021) · Oncology in Clinical Practice · doi:10.5603/ocp.2021.0011 · Cited by 6
Comprehensive Risk Management Chart for Cerebro-cardiovascular Disease 2019
脳心血管病協議会 (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.1024 · Cited by 4
Batra, A., Mann, K. F., Berner, M. M., & Günthner, A. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-22485-0.00009-9 · Cited by 4
Chaisai, C., Patikorn, C., Thavorn, K., Lee, S. W. H., Chaiyakunapruk, N., & Veettil, S. K. (2024) · Addiction · doi:10.1111/add.16464 · Cited by 3
González-Gutiérrez, J. P., Hödar-Salazar, M., Viscarra, F., Paillali, P., Guerra-Díaz, N., Pessoa-Mahana, H. A., Morante, J. J. H., Pérez‐Sánchez, H., Bermúdez, I., Reyes-Parada, M. I., et al. (2019) · Molecules · doi:10.3390/molecules24152684 · Cited by 4
A Review on COPD Treatment and Management Strategies
Vora, S. N., & Shah, P. C. (2019) · International Journal of Research in Advent Technology · doi:10.32622/ijrat.71201987 · Cited by 3
Carney, G., Maclure, M., Bassett, K. L., Taylor, S., & Dormuth, C. R. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4926 · Cited by 3
The Usability of an Online Tool to Promote the Use of Evidence-Based Smoking Cessation Interventions
Zijlstra, D. N., Bolman, C. A. W., Muris, J. W. M., & de Vries, H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010836 · Cited by 3
Park, S., Kang, D.-W., & Lee, E. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac172 · Cited by 3
Update on tobaccoism, approach from the community pharmacy and pharmacological treatments of choice
Juanola, M. C. A. (2022) · Anales de la Real Academia Nacional de Farmacia · doi:10.53519/analesranf.2022.88.03.05 · Cited by 2
The Role of Physiotherapists in Smoking Cessation Management: A Scoping Review
Darabseh, M. Z., Aburub, A., & Fayed, E. E. (2023) · Healthcare · doi:10.3390/healthcare11030336 · Cited by 3
Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders
Castaldelli-Maia, J. M., de Oliveira, V. C., Irber, F. M., Blaas, I. K., Angerville, B., Martins-da-Silva, A. S., Gimenes, G. K., Campos, M. W., Torales, J. C., Ventriglio, A., et al. (2023) · International Review of Psychiatry · doi:10.1080/09540261.2023.2249084 · Cited by 3
Walker, N. K., Calder, A. J., Barnes, J., Laking, G. R., Parag, V., & Bullen, C. (2023) · BMC Public Health · doi:10.1186/s12889-023-16665-w · Cited by 4
Apostol, M., Jordan, T. R., Leuchter, A. F., & Petersen, N. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00154-5 · Cited by 3
Khanagar, S. B., Albalawi, F., Alshehri, A., Awawdeh, M. A., Iyer, K., Bijai, L. K., Aldhebaib, A., & Singh, O. G. (2024) · Cureus · doi:10.7759/cureus.56451 · Cited by 3
García, R. M., Fernández-García, D., Fernández-Martínez, M. N., Villoria, M. G. E., Rodríguez, L. A., & Cimarras, M. A. R. (2024) · Atención Primaria · doi:10.1016/j.aprim.2024.103049 · Cited by 3
Johnstone, S., Cooper, R. K., Wray, J. M., Tonkin, S., Knapp, K. S., Colder, C. R., Maguin, E., Mahoney, M. C., Tiffany, S. T., Brandon, T. H., et al. (2025) · Addiction · doi:10.1111/add.16772 · Cited by 4
Tedesco, E., Ceccato, S., Torazzi, A., Santin, L., Losso, L., Bottardi, A., Casari, R., Melchiori, S., Secchettin, E., Ferrero, V., et al. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-03888-5 · Cited by 3
Pharmacological Management of People Living with End-Stage Chronic Obstructive Pulmonary Disease
Dalgliesh, V., & Pinnock, H. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0440-3 · Cited by 3
(2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.erm9020 · Cited by 3
A dohányzásleszokás-támogatás első vonalbeli gyógyszeres terápiájának aktualitásai
Watti, J., Mohos, A., Kelemen, O., & Pócs, D. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32223 · Cited by 4
Metadata
- Authors
- Cahill, K., Lindson-Hawley, N., Thomas, K. H., Fanshawe, T. R., & Lancaster, T.
- Affiliations
- University of Oxford (GB)
- University of Oxford; Nuffield Department of Primary Care Health Sciences; Radcliffe Observatory Quarter Woodstock Road Oxford UK OX2 6GG
- University of Bristol (GB)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-05-09
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4294253676
- Cited by
- 433
- References
- 230
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 32 · 2023: 57 · 2022: 55 · 2021: 65 · 2020: 34 · 2019: 52 · 2018: 49 · 2017: 43 · 2016: 8
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Update notices
- new_version (2023-05-05)
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion, other-oa)
- Research Portal (King's College London) (submittedVersion)
- Explore Bristol Research (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (15/58/18, HTA/15/58/18, CL-2013-25-003)
- Academy of Medical Sciences (AMS-SGCL12-Thomas)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- nicotine receptor partial agonist, smoking cessation, nicotine replacement therapy, varenicline, bupropion, nicotine dependence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
